Brief: Ironwood Pharmaceuticals Reports Second Quarter 2022 Results

Ironwood Pharmaceuticals

04/08/2022 12:23

Aug 4 (Reuters) - Ironwood Pharmaceuticals Inc  IRWD.O :
    * IRONWOOD PHARMACEUTICALS REPORTS SECOND QUARTER 2022
RESULTS;
MAINTAINS FULL YEAR GUIDANCE DUE TO CONTINUED STRENGTH OF
LINZESS® PRESCRIPTION DEMAND
    * QTRLY GAAP EPS - BASIC $0.24
    * QTRLY NON-GAAP EPS BSIC $0.24
    * REITERATES 2022 GUIDANCE OF U.S. LINZESS NET SALES GROWTH
    * QTRLY TOTAL REVENUE $97.23 MILLION
    * Q2 EARNINGS PER SHARE VIEW $0.30, REVENUE VIEW $103.5
MILLION --
REFINITIV IBES DATA

Source text for Eikon:  ID:nBw3sBt2Sa 
Further company coverage:  IRWD.O 

 ((Reuters.Briefs@thomsonreuters.com;))